Loring Wolcott & Coolidge Fiduciary Advisors’s Amdocs DOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-26
Closed -$2K 799
2021
Q2
$2K Buy
+26
New +$2.01K ﹤0.01% 845
2021
Q1
Sell
-35
Closed -$2K 414
2020
Q4
$2K Buy
+35
New +$2.2K ﹤0.01% 742
2016
Q3
Sell
-240
Closed -$14K 611
2016
Q2
$14K Hold
240
﹤0.01% 516
2016
Q1
$15K Hold
240
﹤0.01% 501
2015
Q4
$13K Hold
240
﹤0.01% 542
2015
Q3
$13K Hold
240
﹤0.01% 525
2015
Q2
$13K Hold
240
﹤0.01% 525
2015
Q1
$13K Hold
240
﹤0.01% 542
2014
Q4
$11K Hold
240
﹤0.01% 543
2014
Q3
$11K Hold
240
﹤0.01% 528
2014
Q2
$11K Hold
240
﹤0.01% 553
2014
Q1
$11K Hold
240
﹤0.01% 540
2013
Q4
$10K Hold
240
﹤0.01% 525
2013
Q3
$9K Hold
240
﹤0.01% 500
2013
Q2
$9K Buy
+240
New +$8.57K ﹤0.01% 539

Other funds holding DOX

Loring Wolcott & Coolidge Fiduciary Advisors's DOX Position: Q3 2021 in Review

Loring Wolcott & Coolidge Fiduciary Advisors sold out of Amdocs (DOX) in Q3 2021, closing a stake of 26 shares — an estimated $2K sold.

Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in DOX in Q2 2013 and held it in 15 quarters. The position peaked at $15K in Q1 2016. 412 funds tracked by Wall St. Rank hold DOX as of Q3 2021.

  • Loring Wolcott & Coolidge Fiduciary Advisors reported no remaining Amdocs position as of Q3 2021 after selling out during the quarter.
  • Loring Wolcott & Coolidge Fiduciary Advisors sold 26 Amdocs shares in Q3 2021, an estimated $2K.
  • Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in Amdocs in Q2 2013 and held it in 15 quarters.
  • Loring Wolcott & Coolidge Fiduciary Advisors's Amdocs position peaked at $15K in Q1 2016.
  • 412 funds tracked by Wall St. Rank held Amdocs as of Q3 2021.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.